PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Vivanti

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Vivanti Company Heralded the Appearance of the Newest Generation of CLM Platforms for Implementation - The Vivanti Company acted as the Gold Sponsor of the III Annual Congress on Electronic Marketing in the Pharmaceutical Industry “Pharma eMarketing 2013”, which took place on September 11-13 in Barcelona - Vivanti.ru
Vivanti Company Heralded the Appearance of the Newest Generation of CLM Platforms for Implementation

 

NewswireToday - /newswire/ - Moscow, Russia, 2013/09/24 - The Vivanti Company acted as the Gold Sponsor of the III Annual Congress on Electronic Marketing in the Pharmaceutical Industry “Pharma eMarketing 2013”, which took place on September 11-13 in Barcelona - Vivanti.ru.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The topics that attracted the most interest of the 2013 conference participants were the issues of interaction with professional medicinal audience using social media. The discussion of electronic detailing (e-detailing/clm) was scheduled for a separate day of the conference (September 13) and attracted live interest, which resulted in a vivid discussion. The background of the discussion comprised the experience of pilot implementations, resulting in a comprehensive opinion on the key factors of success at the e-detailing/clm implementation. This array of opinions transformed into a detailed feedback with a goal-oriented discussion of the project details both during preparation of implementation and during the implementation itself.

The report by Vivanti on the methodology of CLM implementation attracted particular attention. There were so many questions that the discussion continued within the framework of the specially arranged 40-minute panel meeting, at which the conference participants shared their experience of e-detailing/clm implementation, discussed mistakes and important landmarks of projects, listened to Best Practice cases compiled upon the results of Vivanti's implementations. Demonstration of the content and the platform both within the framework of the specially prepared report by Vivanti and at the equipped mount attracted practical interest. The opinion leaders and the leading experts of European representative offices and global offices of pharmaceutical companies, such as Berlin Chemie, Lunbeck, Lilly, Gedeon Richter, Mylan, paid interest to the Call-n-Go platform of the Vivanti Company, and now the conditions of the product implementation in such countries as France, Lebanon, Sweden, Germany and Russia are being discussed.

The opinion of the participants on the convenience and functionality of the Call-n-Go platform of the Vivanti Company (vivanti.ru) is based on the self-sufficiency of the business architecture and information logics interfaces. Functions, which are the platform's basic functionality both at the client side on a tablet and at the server side in the format of a web page, describe and support as fully as possible the main business processes “in the fields”. Participants of the conference expressed a shared opinion that the time of a new generation of more functional solutions has come. The pharmaceutical world has reached the end of the previous platforms’ epoch when only few experts understood the ideology, and the technology went behind the ideology. Actually, having opened the new epoch of highly intellectual solutions, the Call-n-go platform demonstrated on its own example that the application and the content really help professionals “in the fields” to correctly and efficiently arrange marketing communications and territory management.

The Vivanti Company (ZAO “Vivanti”) was founded in 2010 and belongs to the vertically integrated ALP Group of Companies. The Vivanti’s sphere of competence is high-level service in the sphere of information technology, medicinal educational programs (CME), the sphere of database management and improvement of database operation efficiency (CRM, CLM), and in the development of new communication channels and the pharmaceutical marketing. Clients of the company are the leading pharmaceutical companies both on the level of local representative offices and on the global level of parent organizations.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Vivanti

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Vivanti Company Heralded the Appearance of the Newest Generation of CLM Platforms for Implementation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mikhail Moskvinov - Vivanti.ru 
+7 4957850300 Mikhail.Moskvinov[.]vivanti.ru
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Vivanti securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Vivanti / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  SKS Media | SKS Associates Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)